A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022
The sale is expected to close in the first quarter of 2022
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The total cost of the project is estimated at Rs 30 crore
Vakrangee’s distribution network across rural India will help penetrate underserved markets
Collaboration designed to bring reproductive health screening capabilities to hospitals and clinics across the country
Subscribe To Our Newsletter & Stay Updated
